Published in J Bone Miner Res on February 01, 1997
The interaction of PCP and HAp in vivo. J Bone Miner Res (1997) 0.75
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
NDT80, a meiosis-specific gene required for exit from pachytene in Saccharomyces cerevisiae. Mol Cell Biol (1995) 3.82
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation (1999) 3.44
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol (2001) 2.91
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49
The DYT1 phenotype and guidelines for diagnostic testing. Neurology (2000) 2.39
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
Induction and catabolite repression of alpha-glucosidase synthesis in protoplasts of Saccharomyces carlsbergensis. Biochim Biophys Acta (1969) 2.19
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90
The UV response involving the Ras signaling pathway and AP-1 transcription factors is conserved between yeast and mammals. Cell (1994) 1.85
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
The 'essentials' of essential palatal tremor: a reappraisal of the nosology. Brain (2005) 1.78
alpha-Synuclein and Parkinson disease susceptibility. Neurology (2007) 1.72
Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry (2009) 1.70
Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol (1999) 1.67
Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology (2008) 1.60
Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol (2003) 1.56
Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Neuropediatrics (2007) 1.52
Neurosurgical intervention for cervical disk disease in dystonic cerebral palsy. Mov Disord (1998) 1.51
Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica. Infect Immun (1978) 1.47
Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem (1999) 1.45
Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment? Neth J Med (2004) 1.44
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest (1996) 1.44
Eleven-year study of hydroxyapatite implants. J Prosthet Dent (1989) 1.43
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci? Neurology (2007) 1.42
Histological evaluation of biocompatible orthopaedic polymer. Biomaterials (1990) 1.41
Parkinson's disease in twins: a follow-up study. Neurology (1999) 1.40
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
[Treatment of sialorrhea with botulinum toxin: an overview]. Nervenarzt (2005) 1.38
The effect of halothane on the recirculatory pharmacokinetics of physiologic markers. Anesthesiology (1997) 1.38
High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology (2005) 1.34
Induction of phosphodiesterase by cyclic adenosine 3':5'-monophosphate in differentiating Dictyostelium discoideum amoebae. J Biol Chem (1975) 1.33
Fate of virus DNA in the abortive infection of human lymphoid cell lines by Epstein-Barr virus. J Gen Virol (1972) 1.33
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology (2002) 1.32
Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology (1999) 1.31
Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. Biochemistry (2001) 1.30
Adenylate cyclase activity in Dictyostelium discoideum amoebae and its changes during differentiation. FEBS Lett (1976) 1.27
Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry (2006) 1.27
cAMP,-induced changes in cAMP-binding sites on D; discoideum amebae. Cell (1977) 1.26
Transoral decompression, anterior plate fixation, and posterior wire fusion for irreducible atlantoaxial kyphosis in rheumatoid arthritis. Spine (Phila Pa 1976) (2000) 1.26
Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology (2001) 1.25
Tumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is highly induced by tumor necrosis factor-alpha and adipose conversion. J Biol Chem (2001) 1.22
Growth phase-dependent regulation and membrane localization of SpaB, a protein involved in biosynthesis of the lantibiotic subtilin. Appl Environ Microbiol (1994) 1.21
Microassay for the assessment of low levels of hydroxyproline. Biotechniques (1997) 1.21
Clinical findings of a myoclonus-dystonia family with two distinct mutations. Neurology (2002) 1.20
Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp Neurol (2009) 1.19
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain (2005) 1.18
Phenotypic features of myoclonus-dystonia in three kindreds. Neurology (2002) 1.17
Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology (2004) 1.15
Biodegradation behavior of various calcium phosphate materials in bone tissue. J Biomed Mater Res (1983) 1.14
Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology (2007) 1.12
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology (2002) 1.12
cAMP induces a rapid and reversible modification of the chemotactic receptor in Dictyostelium discoideum. J Cell Biol (1985) 1.11
Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat (2008) 1.10
Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) (2001) 1.10
New challenges for informed consent through whole genome array testing. J Med Genet (2009) 1.10
Quality assurance for pharmacy-prepared sterile products in hospitals and home infusion facilities. Am J Health Syst Pharm (1996) 1.10
Effects of cyclic AMP pulses on adenylate cyclase and the phosphodiesterase inhibitor of D. discoideum. Nature (1977) 1.09
Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod (2000) 1.09
Physical and functional heterogeneity in TYMV RNA: evidence for the existence of an independent messenger coding for coat protein. Nucleic Acids Res (1976) 1.09
Involvement of calcium and calmodulin in Toxoplasma gondii tachyzoite invasion. Eur J Cell Biol (1997) 1.08
Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet (2001) 1.08
Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol (2001) 1.08
Electron tomography of metaphase nucleolar organizer regions: evidence for a twisted-loop organization. Mol Biol Cell (1997) 1.08
Topographic organization of the ventral striatal efferent projections in the rhesus monkey: an anterograde tracing study. J Comp Neurol (1990) 1.08
The relationship of phosphodiesterase to the developmental cycle of Dictyostelium discoideum. Biochem Biophys Res Commun (1975) 1.08
Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J Natl Cancer Inst (1995) 1.07
Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology (2002) 1.07
Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett (2001) 1.06
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. Parkinsonism Relat Disord (1997) 1.06
Glycosaminoglycans in myxoma of the jaw: a biochemical study. J Oral Pathol (1985) 1.06
Gender differences in problem severity at assessment and treatment retention. J Subst Abuse Treat (2001) 1.05
The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics (1999) 1.05
The function of the periplasmic Sud protein in polysulfide respiration of Wolinella succinogenes. Eur J Biochem (1998) 1.05
The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol (2013) 1.05
Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol (2000) 1.04
Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology (2007) 1.04
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology (2008) 1.03
Monoclonal antibodies: use to detect developmentally regulated antigens on D. discoideum amebae. Cell (1983) 1.03
Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Eur J Radiol (2007) 1.03
Yeast signal peptidase contains a glycoprotein and the Sec11 gene product. Proc Natl Acad Sci U S A (1991) 1.02
Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun (2001) 1.02
Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J Neurol (2007) 1.01
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Mov Disord (2005) 1.01
Loss of thrombospondin transcriptional activity in nickel-transformed cells. Mol Cell Biol (1994) 1.01
Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes. J Exp Med (2000) 1.01
Calcium ion effects on cyclic adenosine 3':5'-monophosphate bindings to the plasma membrane of Dictyostelium discoideum. Biochim Biophys Acta (1977) 1.00
Nitric oxide regulation of glyceraldehyde-3-phosphate dehydrogenase activity in Dictyostelium discoideum cells and lysates. Eur J Biochem (1994) 0.99
cAMP regulation of cell differentiation in Dictyostelium discoideum and the role of the cAMP receptor. Dev Biol (1981) 0.98
Magnetic resonance real-time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson (2000) 0.97
Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin. Clin Infect Dis (1996) 0.97
Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis. Biol Reprod (2000) 0.97
Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13. Ann Neurol (1999) 0.96